Search

Your search keyword '"Engel, Bastian"' showing total 48 results

Search Constraints

Start Over You searched for: Author "Engel, Bastian" Remove constraint Author: "Engel, Bastian"
48 results on '"Engel, Bastian"'

Search Results

1. Detection of polyreactive immunoglobulin G facilitates diagnosis in children with autoimmune hepatitis

6. Deep Learning helps discriminating Autoimmune Hepatitis and Primary Biliary Cholangitis

8. Histological and serological features of acute liver injury after SARS-CoV-2 vaccination

9. OS-066-YI Polyreactive immunoglobulin G is elevated in autoimmune hepatitis and drug-induced autoimmune-like hepatitis compared to self-limiting drug-induced liver injury

10. WED-160 Autoantibody diagnostics in pediatric non-viral liver diseases: a multicenter retrospective head-to-head comparison of immunofluorescence- and enzyme-linked immunosorbent assay-based testing

11. OS-017 Deep learning discriminates autoimmune hepatitis and primary biliary cholangitis

12. THU-182 Acute liver injury with autoimmune features following SARS-CoV-2 vaccination in an ERN/IAIHG cohort: autoimmune hepatitis versus drug-induced autoimmune-like hepatitis

16. Liver infiltrating T cells regulate bile acid metabolism in experimental cholangitis

19. Results of the prospective multicentre European R-LIVER registry reveal the unmet clinical needs of autoimmune hepatitis

21. The impact of a complete biochemical response on health-related quality of life in patients with autoimmune hepatitis: a multicentre prospective cross-sectional study

24. Reduced humoral but stable cellular SARS-CoV-2-specific immunity in liver transplant recipients in the first year after COVID-19

26. Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) specific cellular and humoral immunity in Corovavirus Disease-2019 (COVID-19) convalescence after liver transplantation-a prospective six month follow-up

27. Corrigendum to ‘Therapeutic HNF4A mRNA attenuates liver fibrosis in a preclinical model’ [J Hepatol (2021) 1420-1433]

29. OS-021-YI Molecular phenotype of chronic antibody-mediated rejection in liver transplant biopsies

30. mRNA therapeutics for liver diseases: HNF4A mRNA delivery via lipid nanoparticles attenuates liver fibrosis in preclinical models.

31. Therapeutic HNF4A mRNA attenuates liver fibrosis in a preclinical model

32. Distinct Immune Imprints of Post–Liver Transplantation Hepatitis C Persist Despite Viral Clearance

33. Liver-first strategy for a combined lung and liver transplant in patients with cystic fibrosis

34. THU-304 - The impact of a complete biochemical response on health-related quality of life in patients with autoimmune hepatitis: a multicentre prospective cross-sectional study

36. OS-047-YI - Results of the prospective multicentre European R-LIVER registry reveal the unmet clinical needs of autoimmune hepatitis

37. CK‐18 cell death markers improve the prediction of histological remission in autoimmune hepatitis during biochemical remission

40. Quantification of polyreactive immunoglobulin G facilitates the diagnosis of autoimmune hepatitis.

41. THU-003-European multicenter validation of autoantibodies against huntingtin-interacting protein 1-related protein for the diagnosis of autoimmune hepatitis in adults

42. CK‐18 cell death markers improve the prediction of histological remission in autoimmune hepatitis during biochemical remission.

44. Unmet needs in autoimmune hepatitis: Results of the prospective multicentre European Reference Network Registry (R‐LIVER)

46. Identification and functional validation of miR-190b-5p and miR-296-3p as novel therapeutic attenuators of liver fibrosis.

47. Prospective comparison of liver stiffness measurement methods in surveillance biopsies after liver transplantation.

48. Histological and serological features of acute liver injury after SARS-CoV-2 vaccination.

Catalog

Books, media, physical & digital resources